English
简体中文
Total: £ 56.28
Published Date: 2024-03-29 | Pages: 80 | Tables: 160 | Medical Care
The global Medicine Treat BPH market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Medicine Treat BPH, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicine Treat BPH.
Report Scope
The Medicine Treat BPH market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medicine Treat BPH market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicine Treat BPH companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
GlaxoSmithKline
Astellas Pharma
Sanofi
Pfizer
Abbott
Allergan
TEVA
Mylan
Novartis
Merck
Segment by Type
Alpha-Blocker
Phosphodiesterase Type-5 Inhibitors
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medicine Treat BPH companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medicine Treat BPH Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Alpha-Blocker
1.2.3 Phosphodiesterase Type-5 Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Medicine Treat BPH Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medicine Treat BPH Market Perspective (2019-2030)
2.2 Medicine Treat BPH Growth Trends by Region
2.2.1 Global Medicine Treat BPH Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Medicine Treat BPH Historic Market Size by Region (2019-2024)
2.2.3 Medicine Treat BPH Forecasted Market Size by Region (2025-2030)
2.3 Medicine Treat BPH Market Dynamics
2.3.1 Medicine Treat BPH Industry Trends
2.3.2 Medicine Treat BPH Market Drivers
2.3.3 Medicine Treat BPH Market Challenges
2.3.4 Medicine Treat BPH Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medicine Treat BPH Players by Revenue
3.1.1 Global Top Medicine Treat BPH Players by Revenue (2019-2024)
3.1.2 Global Medicine Treat BPH Revenue Market Share by Players (2019-2024)
3.2 Global Medicine Treat BPH Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medicine Treat BPH Revenue
3.4 Global Medicine Treat BPH Market Concentration Ratio
3.4.1 Global Medicine Treat BPH Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medicine Treat BPH Revenue in 2023
3.5 Medicine Treat BPH Key Players Head office and Area Served
3.6 Key Players Medicine Treat BPH Product Solution and Service
3.7 Date of Enter into Medicine Treat BPH Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medicine Treat BPH Breakdown Data by Type
4.1 Global Medicine Treat BPH Historic Market Size by Type (2019-2024)
4.2 Global Medicine Treat BPH Forecasted Market Size by Type (2025-2030)
5 Medicine Treat BPH Breakdown Data by Application
5.1 Global Medicine Treat BPH Historic Market Size by Application (2019-2024)
5.2 Global Medicine Treat BPH Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Medicine Treat BPH Market Size (2019-2030)
6.2 North America Medicine Treat BPH Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Medicine Treat BPH Market Size by Country (2019-2024)
6.4 North America Medicine Treat BPH Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medicine Treat BPH Market Size (2019-2030)
7.2 Europe Medicine Treat BPH Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Medicine Treat BPH Market Size by Country (2019-2024)
7.4 Europe Medicine Treat BPH Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medicine Treat BPH Market Size (2019-2030)
8.2 Asia-Pacific Medicine Treat BPH Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Medicine Treat BPH Market Size by Region (2019-2024)
8.4 Asia-Pacific Medicine Treat BPH Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medicine Treat BPH Market Size (2019-2030)
9.2 Latin America Medicine Treat BPH Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Medicine Treat BPH Market Size by Country (2019-2024)
9.4 Latin America Medicine Treat BPH Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medicine Treat BPH Market Size (2019-2030)
10.2 Middle East & Africa Medicine Treat BPH Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Medicine Treat BPH Market Size by Country (2019-2024)
10.4 Middle East & Africa Medicine Treat BPH Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Medicine Treat BPH Introduction
11.1.4 Eli Lilly Revenue in Medicine Treat BPH Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Medicine Treat BPH Introduction
11.2.4 GlaxoSmithKline Revenue in Medicine Treat BPH Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Detail
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Medicine Treat BPH Introduction
11.3.4 Astellas Pharma Revenue in Medicine Treat BPH Business (2019-2024)
11.3.5 Astellas Pharma Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Medicine Treat BPH Introduction
11.4.4 Sanofi Revenue in Medicine Treat BPH Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Medicine Treat BPH Introduction
11.5.4 Pfizer Revenue in Medicine Treat BPH Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Medicine Treat BPH Introduction
11.6.4 Abbott Revenue in Medicine Treat BPH Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Allergan
11.7.1 Allergan Company Detail
11.7.2 Allergan Business Overview
11.7.3 Allergan Medicine Treat BPH Introduction
11.7.4 Allergan Revenue in Medicine Treat BPH Business (2019-2024)
11.7.5 Allergan Recent Development
11.8 TEVA
11.8.1 TEVA Company Detail
11.8.2 TEVA Business Overview
11.8.3 TEVA Medicine Treat BPH Introduction
11.8.4 TEVA Revenue in Medicine Treat BPH Business (2019-2024)
11.8.5 TEVA Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Medicine Treat BPH Introduction
11.9.4 Mylan Revenue in Medicine Treat BPH Business (2019-2024)
11.9.5 Mylan Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Medicine Treat BPH Introduction
11.10.4 Novartis Revenue in Medicine Treat BPH Business (2019-2024)
11.10.5 Novartis Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Medicine Treat BPH Introduction
11.11.4 Merck Revenue in Medicine Treat BPH Business (2019-2024)
11.11.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Medicine Treat BPH Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Alpha-Blocker
Table 3. Key Players of Phosphodiesterase Type-5 Inhibitors
Table 4. Key Players of Others
Table 5. Global Medicine Treat BPH Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Medicine Treat BPH Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Medicine Treat BPH Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Medicine Treat BPH Market Share by Region (2019-2024)
Table 9. Global Medicine Treat BPH Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Medicine Treat BPH Market Share by Region (2025-2030)
Table 11. Medicine Treat BPH Market Trends
Table 12. Medicine Treat BPH Market Drivers
Table 13. Medicine Treat BPH Market Challenges
Table 14. Medicine Treat BPH Market Restraints
Table 15. Global Medicine Treat BPH Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Medicine Treat BPH Market Share by Players (2019-2024)
Table 17. Global Top Medicine Treat BPH Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine Treat BPH as of 2023)
Table 18. Ranking of Global Top Medicine Treat BPH Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Medicine Treat BPH Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Medicine Treat BPH Product Solution and Service
Table 22. Date of Enter into Medicine Treat BPH Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Medicine Treat BPH Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Medicine Treat BPH Revenue Market Share by Type (2019-2024)
Table 26. Global Medicine Treat BPH Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Medicine Treat BPH Revenue Market Share by Type (2025-2030)
Table 28. Global Medicine Treat BPH Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Medicine Treat BPH Revenue Market Share by Application (2019-2024)
Table 30. Global Medicine Treat BPH Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Medicine Treat BPH Revenue Market Share by Application (2025-2030)
Table 32. North America Medicine Treat BPH Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Medicine Treat BPH Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Medicine Treat BPH Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Medicine Treat BPH Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Medicine Treat BPH Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Medicine Treat BPH Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Medicine Treat BPH Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Medicine Treat BPH Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Medicine Treat BPH Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Medicine Treat BPH Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Medicine Treat BPH Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Medicine Treat BPH Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Medicine Treat BPH Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Medicine Treat BPH Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Medicine Treat BPH Market Size by Country (2025-2030) & (US$ Million)
Table 47. Eli Lilly Company Detail
Table 48. Eli Lilly Business Overview
Table 49. Eli Lilly Medicine Treat BPH Product
Table 50. Eli Lilly Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 51. Eli Lilly Recent Development
Table 52. GlaxoSmithKline Company Detail
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Medicine Treat BPH Product
Table 55. GlaxoSmithKline Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 56. GlaxoSmithKline Recent Development
Table 57. Astellas Pharma Company Detail
Table 58. Astellas Pharma Business Overview
Table 59. Astellas Pharma Medicine Treat BPH Product
Table 60. Astellas Pharma Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 61. Astellas Pharma Recent Development
Table 62. Sanofi Company Detail
Table 63. Sanofi Business Overview
Table 64. Sanofi Medicine Treat BPH Product
Table 65. Sanofi Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Pfizer Company Detail
Table 68. Pfizer Business Overview
Table 69. Pfizer Medicine Treat BPH Product
Table 70. Pfizer Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Abbott Company Detail
Table 73. Abbott Business Overview
Table 74. Abbott Medicine Treat BPH Product
Table 75. Abbott Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. Allergan Company Detail
Table 78. Allergan Business Overview
Table 79. Allergan Medicine Treat BPH Product
Table 80. Allergan Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 81. Allergan Recent Development
Table 82. TEVA Company Detail
Table 83. TEVA Business Overview
Table 84. TEVA Medicine Treat BPH Product
Table 85. TEVA Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 86. TEVA Recent Development
Table 87. Mylan Company Detail
Table 88. Mylan Business Overview
Table 89. Mylan Medicine Treat BPH Product
Table 90. Mylan Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. Novartis Company Detail
Table 93. Novartis Business Overview
Table 94. Novartis Medicine Treat BPH Product
Table 95. Novartis Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Medicine Treat BPH Product
Table 100. Merck Revenue in Medicine Treat BPH Business (2019-2024) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medicine Treat BPH Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Medicine Treat BPH Market Share by Type: 2023 VS 2030
Figure 3. Alpha-Blocker Features
Figure 4. Phosphodiesterase Type-5 Inhibitors Features
Figure 5. Others Features
Figure 6. Global Medicine Treat BPH Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Medicine Treat BPH Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Drugstores Case Studies
Figure 10. Others Case Studies
Figure 11. Medicine Treat BPH Report Years Considered
Figure 12. Global Medicine Treat BPH Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Medicine Treat BPH Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Medicine Treat BPH Market Share by Region: 2023 VS 2030
Figure 15. Global Medicine Treat BPH Market Share by Players in 2023
Figure 16. Global Top Medicine Treat BPH Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine Treat BPH as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Medicine Treat BPH Revenue in 2023
Figure 18. North America Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Medicine Treat BPH Market Share by Country (2019-2030)
Figure 20. United States Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Medicine Treat BPH Market Share by Country (2019-2030)
Figure 24. Germany Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Medicine Treat BPH Market Share by Region (2019-2030)
Figure 32. China Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Medicine Treat BPH Market Share by Country (2019-2030)
Figure 40. Mexico Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Medicine Treat BPH Market Share by Country (2019-2030)
Figure 44. Turkey Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Medicine Treat BPH Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Eli Lilly Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 48. Astellas Pharma Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 50. Pfizer Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 51. Abbott Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 52. Allergan Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 53. TEVA Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 54. Mylan Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 55. Novartis Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Medicine Treat BPH Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
